{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:03:25Z","timestamp":1782299005801,"version":"3.54.5"},"reference-count":94,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jaip.2016.06.020","type":"journal-article","created":{"date-parts":[[2016,8,14]],"date-time":"2016-08-14T02:04:37Z","timestamp":1471140277000},"page":"13-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Local Side Effects of Sublingual and Oral Immunotherapy"],"prefix":"10.1016","volume":"5","author":[{"given":"Giovanni","family":"Passalacqua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nowak-W\u0119grzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio Walter","family":"Canonica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2016.06.020_bib1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1067\/mai.2003.129","article-title":"Noninjection routes for immunotherapy","volume":"111","author":"Canonica","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib2","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/bmj.293.6552.948","article-title":"CSM update: desensitizing vaccines","volume":"293","author":"Committee on the Safety of Medicines","year":"1986","journal-title":"Br Med J"},{"key":"10.1016\/j.jaip.2016.06.020_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.iac.2015.08.001","article-title":"Allergen immunotherapy: history and future developments","volume":"36","author":"Passalacqua","year":"2016","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2016.06.020_bib4","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jaci.2004.01.756","article-title":"Incorrect allergy injections: allergists' experiences and recommendations for prevention","volume":"113","author":"Aaronson","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/ACI.0b013e32831845fb","article-title":"An update on the safety of specific immunotherapy","volume":"8","author":"Windom","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2222.1986.tb01983.x","article-title":"Low dose sublingual therapy in patients with allergic rhinitis due to dust mite","volume":"16","author":"Scadding","year":"1986","journal-title":"Clin Allergy"},{"issue":"44 Suppl","key":"10.1016\/j.jaip.2016.06.020_bib7","first-page":"1","article-title":"Allergen immunotherapy: therapeutical vaccines for allergic diseases","volume":"53","author":"Bousquet","year":"1998","journal-title":"World Health Organization position paper"},{"key":"10.1016\/j.jaip.2016.06.020_bib8","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1398-9995.1998.tb03793.x","article-title":"EAACI position paper on local immunotherapy","volume":"53","author":"Malling","year":"1998","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.06.020_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.06.020_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1398-9995.2009.02309.x","article-title":"Sub-lingual immunotherapy: World Allergy Organization position paper 2009","volume":"64","author":"Canonica","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.06.020_bib11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1939-4551-7-6","article-title":"Sublingual immunotherapy: World Allergy Organization position paper 2013 update","volume":"7","author":"Canonica","year":"2014","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2016.06.020_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.anai.2015.03.022","article-title":"Sublingual immunotherapy: focus on tablets","volume":"115","author":"Passalacqua","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.iac.2014.09.011","article-title":"Potential treatments for food allergy","volume":"35","author":"Albin","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2016.06.020_bib14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jaci.2013.12.1040","article-title":"State of the art on food allergen immunotherapy: oral, sublingual, and epicutaneous","volume":"133","author":"Jones","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1586\/1744666X.2016.1102058","article-title":"Efficacy and safety of sublingual immunotherapy in children","volume":"12","author":"Arasi","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1398-9995.2005.00699.x","article-title":"Sublingual immunotherapy for allergic rhinitis","volume":"60","author":"Wilson","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.06.020_bib17","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1398-9995.2006.01205.x","article-title":"Efficacy of sublingual immunotherapy in asthma: systematic review of randomized clinical trials","volume":"61","author":"Calamita","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.06.020_bib18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1378\/chest.06-1425","article-title":"Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age","volume":"133","author":"Penagos","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2016.06.020_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1081-1206(10)60004-X","article-title":"Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials","volume":"97","author":"Penagos","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib20","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/j.1398-9995.2009.02129.x","article-title":"The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis","volume":"64","author":"Compalati","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.06.020_bib21","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jaci.2010.06.013","article-title":"Efficacy of\u00a0sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a systematic review and meta-analysis","volume":"126","author":"Di Bona","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib22","first-page":"CD002893","article-title":"Sublingual immunotherapy for allergic rhinitis","volume":"8","author":"Radulovic","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2016.06.020_bib23","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/jamainternmed.2015.2840","article-title":"Efficacy of grass pollen allergen sublingual immunotherapy tablets for seasonal allergic rhinoconjunctivitis: a systematic review and meta-analysis","volume":"175","author":"Di Bona","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaip.2016.06.020_bib24","first-page":"CD007685","article-title":"Sublingual immunotherapy for treating allergic conjunctivitis","volume":"6","author":"Calderon","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2016.06.020_bib25","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jaci.2006.02.040","article-title":"Sublingual immunotherapy: a comprehensive review","volume":"117","author":"Cox","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1398-9995.2011.02761.x","article-title":"Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile","volume":"67","author":"Calder\u00f3n","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.06.020_bib27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1398-9995.2005.00949.x","article-title":"Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis","volume":"61","author":"Dahl","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.06.020_bib28","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jaci.2005.12.1358","article-title":"Sublingual immunotherapy with once-daily grass-allergen tablets: a randomised controlled trial in seasonal allergic rhinoconjunctivitis","volume":"117","author":"Durham","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib29","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jaci.2007.07.046","article-title":"Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis","volume":"120","author":"Didier","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1398-9995.2008.01875.x","article-title":"Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study","volume":"64","author":"Ott","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.06.020_bib31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaci.2008.10.009","article-title":"Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis","volume":"123","author":"Wahn","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaci.2008.10.044","article-title":"Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy","volume":"123","author":"Bufe","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaci.2010.11.034","article-title":"Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents","volume":"127","author":"Blaiss","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaci.2010.11.035","article-title":"Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults","volume":"127","author":"Nelson","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib35","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.jaci.2012.06.047","article-title":"High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study","volume":"130","author":"Wahn","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib36","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jaci.2012.08.032","article-title":"Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE","volume":"130","author":"Cox","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib37","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1399-3038.2011.01219.x","article-title":"Sublingual immunotherapy not effective in house dust mite-allergic children in primary care","volume":"23","author":"de Bot","year":"2012","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib38","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.anai.2013.03.013","article-title":"Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults","volume":"110","author":"Nolte","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib39","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.jaci.2013.03.019","article-title":"Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults","volume":"131","author":"Creticos","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib40","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jaci.2013.11.012","article-title":"Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis","volume":"133","author":"Bergmann","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib41","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jaci.2013.10.041","article-title":"Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis","volume":"133","author":"Creticos","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib42","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jaci.2014.03.019","article-title":"Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial","volume":"134","author":"Mosbech","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib43","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.anai.2013.11.018","article-title":"Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial","volume":"112","author":"Maloney","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib44","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/all.12188","article-title":"House dust mite sublingual immunotherapy is safe and appears to be effective in moderate, persistent asthma","volume":"69","author":"Wang","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.06.020_bib45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000381059","article-title":"Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis","volume":"166","author":"Okamoto","year":"2015","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib46","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1399-3038.2007.00556.x","article-title":"Safety of specific sublingual immunotherapy with SQ standardized grass allergen tablets in children","volume":"18","author":"Ibanez","year":"2007","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib47","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jaci.2011.06.022","article-title":"Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis","volume":"128","author":"Didier","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib48","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1034\/j.1398-9995.1999.00267.x","article-title":"Post-marketing surveillance study on the safety of sublingual immunotherapy in children","volume":"54","author":"Di Rienzo","year":"1999","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.06.020_bib49","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1034\/j.1398-9995.2001.00181.x","article-title":"Safety of sublingual immunotherapy in adults: a post marketing surveillance study","volume":"56","author":"Lombardi","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.06.020_bib50","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2165\/00148581-200305110-00006","article-title":"Safety of sublingual immunotherapy in children with asthma","volume":"5","author":"Pajno","year":"2003","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jaip.2016.06.020_bib51","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1081-1206(10)61222-7","article-title":"Safety of SLIT in children aged 3 to 7 years","volume":"95","author":"Fiocchi","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1398-9995.2004.00616.x","article-title":"Safety of SLIT in very young children","volume":"60","author":"Agostinis","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.06.020_bib53","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2222.2005.02219.x","article-title":"Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years","volume":"35","author":"Di Rienzo","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2016.06.020_bib54","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1081-1206(10)60496-6","article-title":"Frequency of acute systemic reactions in patients with allergic rhinitis and asthma treated with sublingual immunotherapy","volume":"101","author":"Rodr\u00edguez-P\u00e9rez","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib55","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/j.1398-9995.2008.01742.x","article-title":"The safety of sublingual immunotherapy with one or multiple pollen allergens in children","volume":"63","author":"Agostinis","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.06.020_bib56","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1398-9995.2007.01608.x","article-title":"The safety of sublingual immunotherapy with one or more allergens in adults","volume":"63","author":"Lombardi","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.06.020_bib57","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jaci.2013.03.039","article-title":"Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language","volume":"132","author":"Passalacqua","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib58","unstructured":"MedDRA Medical Dictionary for Regulatory Activities. Maintenance Support Services and Organization. Available from: http:\/\/www.meddramsso.com\/. Accessed January 27, 2016."},{"key":"10.1016\/j.jaip.2016.06.020_bib59","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","article-title":"The medical dictionary for regulatory activities (MedDRA)","volume":"20","author":"Brown","year":"1999","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2016.06.020_bib60","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00002018-200528010-00002","article-title":"Appraisal of the MedDRA conceptual structure for describing and grouping adverse drug reactions","volume":"28","author":"Bousquet","year":"2005","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2016.06.020_bib61","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2009.10.060","article-title":"Speaking the same language: the World Allergy Organization subcutaneous immunotherapy systemic reaction grading system","volume":"125","author":"Cox","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib62","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/all.12638","article-title":"Clinical contraindications to allergen immunotherapy: an EAACI position paper","volume":"70","author":"Pitsios","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.06.020_bib63","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jaci.2014.05.013","article-title":"Food allergy: a practice parameter update-2014","volume":"134","author":"Sampson","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib64","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0091-6749(92)90080-L","article-title":"Treatment of peanut allergy with rush immunotherapy","volume":"90","author":"Oppenheimer","year":"1992","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib65","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0091-6749(97)80006-1","article-title":"Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract","volume":"99","author":"Nelson","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib66","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jaci.2005.08.027","article-title":"Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract 2","volume":"116","author":"Enrique","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib67","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaci.2011.10.023","article-title":"The safety and efficacy of sublingual and oral\u00a0immunotherapy for milk allergy","volume":"129","author":"Keet","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib68","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1398-9995.2008.01921.x","article-title":"Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract","volume":"64","author":"Fernandez-Rivas","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2016.06.020_bib69","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jaci.2010.12.1083","article-title":"Sublingual immunotherapy for peanut allergy: clinical and immunological evidence of desensitization","volume":"127","author":"Kim","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib70","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jaci.2012.11.011","article-title":"Sublingual immunotherapy for peanut allergy: a randomized, double-blind,\u00a0placebo-controlled multicenter trial","volume":"131","author":"Fleischer","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib71","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jaci.2014.12.1917","article-title":"Sublingual immunotherapy for peanut allergy: long-term follow-up of a randomized multicenter trial","volume":"135","author":"Burks","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib72","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jaci.2014.11.005","article-title":"A\u00a0randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy","volume":"135","author":"Narisety","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib73","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaci.2010.12.1111","article-title":"A\u00a0randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response","volume":"127","author":"Varshney","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib74","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jaci.2009.05.022","article-title":"Clinical efficacy and immune regulation with peanut oral immunotherapy","volume":"124","author":"Jones","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib75","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0140-6736(13)62301-6","article-title":"Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial","volume":"383","author":"Anagnostou","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2016.06.020_bib76","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jaci.2008.09.030","article-title":"A\u00a0randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy","volume":"122","author":"Skripak","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib77","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jaci.2007.10.029","article-title":"Specific oral tolerance induction in children with very severe cow's milk-induced reactions","volume":"121","author":"Longo","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib78","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.anai.2010.03.015","article-title":"Oral immunotherapy for cow's milk allergy with a weekly up-dosing regimen: a randomized single-blind controlled study","volume":"105","author":"Pajno","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib79","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.jaci.2015.07.019","article-title":"Wheat oral immunotherapy for wheat-induced anaphylaxis","volume":"136","author":"Sato","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib80","first-page":"240","article-title":"Oral immunotherapy in children with IgE-mediated wheat allergy: outcome and molecular changes","volume":"4","author":"Rodriguez del Rio","year":"2014","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib81","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jaci.2010.04.030","article-title":"Oral peanut immunotherapy in children with peanut anaphylaxis","volume":"126","author":"Blumchen","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib82","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1200435","article-title":"Oral immunotherapy for treatment of egg allergy in children","volume":"367","author":"Burks","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2016.06.020_bib83","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/ACI.0b013e3283535b93","article-title":"Oral immunotherapy for cow's milk allergy","volume":"12","author":"Pajno","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib84","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.anai.2014.08.004","article-title":"Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis","volume":"113","author":"Lucendo","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib85","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jaci.2009.06.025","article-title":"Open-label maintenance after milk oral immunotherapy for IgE-mediated cow's milk allergy","volume":"124","author":"Narisety","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib86","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.jaci.2009.09.042","article-title":"Adverse reactions during peanut oral immunotherapy home dosing","volume":"124","author":"Varshney","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib87","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.iac.2011.11.004","article-title":"Oral immunotherapy and anti-IgE antibody-adjunctive treatment for food allergy","volume":"32","author":"Nadeau","year":"2012","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2016.06.020_bib88","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jaci.2011.04.009","article-title":"Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy","volume":"127","author":"Nadeau","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib89","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jaci.2013.09.046","article-title":"A\u00a0pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients","volume":"132","author":"Schneider","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib90","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaci.2015.10.005","article-title":"A\u00a0randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy","volume":"137","author":"Wood","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib91","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1710-1492-10-7","article-title":"Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol\u00a0to\u00a0multiple foods using omalizumab","volume":"10","author":"Begin","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib92","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/pai.12077","article-title":"Comparison between two maintenance feeding regimens after successful cow's milk oral desensitization","volume":"24","author":"Pajno","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib93","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jaci.2015.04.047","article-title":"International consensus on allergy immunotherapy","volume":"136","author":"Jutel","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.06.020_bib94","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaip.2013.10.001","article-title":"Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions","volume":"2","author":"Wasserman","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321981630263X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321981630263X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:11:03Z","timestamp":1761973863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221321981630263X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S221321981630263X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2016.06.020","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local Side Effects of Sublingual and Oral Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2016.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}